Skip to main content
Premium Trial:

Request an Annual Quote

GeneTrace Allies With Monsanto, Names CEO

Premium

MENLO PARK, Calif.--GeneTrace announced it will collaborate with Monsanto on plant and animal genomics research. Monsanto will make a $17.2 million investment in GeneTrace, a genetic information provider based here. Monsanto will get exclusive options to license all aspects of GeneTrace's genomics technologies for plant and animal agriculture worldwide, research and development funding, equipment purchases, supply agreements, and an equity investment. As part of the initial agreement, Monsanto has exercised an option to license GeneTrace's genotyping methods and intends to use the technology for many crops, including corn and soybeans.

GeneTrace also announced that it has appointed George LaMotte to the position of CEO. LaMotte, who holds a PhD in molecular immunology from Cornell and was a fellow in molecular immunology at Scripps Clinic and Research Foundation, most recently served with the healthcare business consultants Owen & Associates.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.